AVOPEF vs POTELIGEO

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated June 7, 2026·How we rate

Possible drug interaction. AVOPEF and POTELIGEO are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	AVOPEF	POTELIGEO
Rating	New	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	ETOPOSIDE	MOGAMULIZUMAB-KPKC
Manufacturer	Avyxa Holdings	Kyowa Kirin
Dosage forms	Injectable	Injectable
Drug class	Topoisomerase Inhibitor	—
Boxed warning	Boxed warning	None
Treats	Urinary Bladder Neoplasms, Brain Neoplasms, Lung Neoplasms	Mycosis Fungoides, Sezary Syndrome

avopef poteligeo

Rating

New

Pharmacy pays

—

Type

Active ingredient

ETOPOSIDE

MOGAMULIZUMAB-KPKC

Manufacturer

Avyxa Holdings

Kyowa Kirin

Dosage forms

Injectable

Drug class

Topoisomerase Inhibitor

—

Boxed warning

None

Treats

Urinary Bladder Neoplasms, Brain Neoplasms, Lung Neoplasms

Mycosis Fungoides, Sezary Syndrome

Frequently asked questions

What is the difference between Avopef and Poteligeo?

Avopef contains Etoposide, while Poteligeo contains Mogamulizumab-Kpkc — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.